Advances in Research and Clinical Trials
One of the main goals of the National Cancer Institute's Community Cancer Centers Program (NCCCP) is to expand clinical trials and offer patient access to the latest trials available-all within their own community. Since the inception of the NCCCP, the Nancy N. and J.C. Lewis Cancer & Research Pavilion (LCRP) has had greater access to clinical trials, expanded the number of clinical trials available to patients, started participating in early phase clinical trials, increased focus on minority and underserved population participation in clinical trials and joined the Eastern Cooperative Oncology Group (ECOG), which provides greater access to national clinical trials.
Robust Clinical Trial Programs
The LCRP at St. Joseph's/Candler has a robust clinical trials program, led by H.A. Zaren, MD, FACS, that includes an affiliate relationship with H. Lee Moffitt Cancer Center, in Tampa, Florida, to allow patients access to additional clinical trials.
The LCRP participates in state, regional and national collaborations with other research sites including: a state collaboration with Georgia CORE; a regional collaboration with Hollings Cancer Center at the Medical University of South Carolina; and a national collaboration with another NCCCP site, Gibbs Cancer Center.
The LCRP also participates in a project on Early Phase Clinical Trial Infrastructure Development, which involves collaborations with the National Cancer Institute and the Medical College of Georgia.
For more information about advanced cancer services at the Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler, please call 912-819-5704.